This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mithra Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18%.

Top 19 shareholders own 52.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.6%	Francois Fornieri	10,809,882	€2.3m	0%	no data
14.5%	Armistice Capital LLC	10,000,000	€2.2m	0%	0.07%
7.94%	Noshaq S.A.	5,488,251	€1.2m	0%	100.0%
4.31%	Alychlo NV	2,975,928	€642.8k	0%	0.17%
3.6%	Goldman Sachs Group, Investment Banking and Securities Investments	2,489,759	€537.8k	0%	no data
2.38%	Bart Versluys	1,641,407	€354.5k	0%	no data
2.16%	Marc Armand Alice Andre Coucke	1,495,481	€323.0k	0%	no data
1%	Christian Moretti	689,655	€149.0k	0%	no data
0.52%	BNPP Asset Management Holding	359,750	€77.7k	0%	no data
0.16%	BNP Paribas Asset Management Europe	111,919	€24.2k	0%	no data
0.067%	Van Rompay Management Bvba	46,125	€10.0k	0%	no data
0.042%	Valerie Gordenne	29,000	€6.3k	0%	no data
0.029%	Jean-Michel Foidart	20,370	€4.4k	0%	no data
0.0029%	Dimensional Fund Advisors LP	2,000	€431.4	-31.6%	no data
0.0024%	Assenagon Asset Management S.A.	1,626	€350.8	0%	no data
0.0011%	Ajit S. Shetty	780	€168.7	0%	no data
0.00075%	State Street Global Advisors, Inc.	516	€112.0	1.57%	no data
0.00005%	Benjamin Brands	35	€7.5	0%	no data
0.00004%	Jean-Manuel Fontaine	28	€6.0	0%	no data